Dyfyniad APA

Tong, W. H. (2016). Comment on 'Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia'. Blood Cancer J.

Dyfyniad Arddull Chicago

Tong, W H. "Comment On 'Blinatumomab Vs Historical Standard Therapy of Adult Relapsed/refractory Acute Lymphoblastic Leukemia'." Blood Cancer J 2016.

Dyfyniad MLA

Tong, W H. "Comment On 'Blinatumomab Vs Historical Standard Therapy of Adult Relapsed/refractory Acute Lymphoblastic Leukemia'." Blood Cancer J 2016.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.